MOR Jun 2024 17.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 1.5000 |
| Open | 1.5000 |
| Bid | 0.3000 |
| Ask | 0.9500 |
| Strike | 17.50 |
| Expiry date | 2024-06-21 |
| Day's range | 1.5000 - 1.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 54 |
ZacksBiogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Biogen's (BIIB) acquisition of private biotech, HI-Bio, is set to expand its rare disease pipeline by adding the latter's lead asset, felzartamab.
Simply Wall St.MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
© 2024 Yahoo. All rights reserved.